Table 2 Prevalence of individual metabolic syndrome component in men and women according to the number of abnormal components
From: Circulating microRNAs have a sex-specific association with metabolic syndrome
Men | Women | |||||||
|---|---|---|---|---|---|---|---|---|
Number of abnormal metabolic components | Number of abnormal metabolic components | |||||||
0-5 | 0-2 | 3 | 4-5 | 0-5 | 0-2 | 3 | 4-5 | |
(All) | (without MS) | (with MS) | (with MS) | (All) | (without MS) | (with MS) | (with MS) | |
(n = 52) | (n = 36) | (n = 12) | (n = 4) | (n = 50) | (n = 35) | (n = 10) | (n = 5) | |
Increased waist circumstance | 25 (48.1%) | 12 (33.3%) | 9 (75.0%) | 4 (100.0%) | 31 (62.0%) | 18 (51.4%) | 8 (80.0%) | 5 (100.0%) |
Decreased HDL | 7 (13.5%) | 0 (0.0%) | 4 (33.3%) | 3 (75.0%) | 14 (28.0%) | 5 (14.3%) | 4 (40.0%) | 5 (100.0%) |
Hypertriglycerides | 10 (19.2%) | 2 (5.6%) | 6 (50.0%) | 2 (50.0%) | 9 (18.0%) | 2 (5.7%) | 2 (20.0%) | 5 (100.0%) |
Hyperglycemia | 19 (36.5%) | 8 (22.2%) | 7 (58.3%) | 4 (100.0%) | 12 (24.0%) | 3 (8.6%) | 6 (60.0%) | 3 (60.0%) |
High blood pressure | 24 (46.2%) | 10 (27.8%) | 10 (83.3%) | 4 (100.0%) | 21 (42.0%) | 8 (22.9%) | 10 (100.0%) | 3 (60.0%) |